Brief: Perrigo Says Letter Co Received From FDA Pertained Only To Infant Formula Manufacturing Facility In Wisconsin, Which Co Got From Nestle On Nov 1, 2022

Perrigo

30/08/2023 23:07

Aug 30 (Reuters) - Perrigo Company PLC  PRGO.N :
    * PERRIGO: LETTER CO RECEIVED FROM FDA PERTAINED ONLY TO
INFANT
FORMULA MANUFACTURING FACILITY IN WISCONSIN, WHICH CO GOT FROM
NESTLE ON NOV 1, 2022
    * PERRIGO COMPANY PLC - FDA LETTER RELATES TO A ROUTINE
INSPECTION
BY THE FDA WHICH BEGAN ON MARCH 6, 2023
    * PERRIGO COMPANY PLC - OUR PRODUCTS ARE SAFE FOR INFANT
FEEDING,
AND FDA DOES NOT ADVISE DISCARDING OR AVOIDING PURCHASE OF ANY
PARTICULAR INFANT FORMULA
    * PERRIGO COMPANY PLC - IN THE PROCESS OF CAREFULLY
REVIEWING
FDA’S LETTER AND PLAN TO WORK CLOSELY WITH THE AGENCY

Source text for Eikon:  ID: 
Further company coverage:  PRGO.N 

 ((Reuters.Brief@thomsonreuters.com;))